Letter to the EditorEfficacy of Immune Checkpoint Inhibitors in SMARCA4-Mutant NSCLC
Under an Elsevier user license
open archive
Cited by (0)
H.Z. and J.S. contributed equally to this article.
© 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc.